Nathalie Auber
@Sofinnova Investments, Inc.
Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.
Assets under management
The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
AVTRAvantor Inc
| 0% | $2.99M 141,045 shares@ $21.2 avg price | Exited |
TFXTeleflex Incorporated
| 0% | $2.871M 13,649 shares@ $210.33 avg price | Exited |
MASIMasimo Corp
| 0% | $2.539M 20,161 shares@ $125.94 avg price | Exited |
INSPInspire Med Sys Inc
| 0% | $1.338M 10,000 shares@ $133.83 avg price | Exited |
ZBHZimmer Biomet Holdings Inc
| 0% | $1.154M 10,630 shares@ $108.54 avg price | Exited |
AMLXAmylyx Pharmaceuticals Inc
| 0% | $1.139M↓ Put 599,691 shares@ $1.91 avg price | Exited |
LIVNLivanova Plc
| 0% | $1.129M 20,602 shares@ $54.83 avg price | Exited |
PDSBPds Biotechnology Corp
| 0% | $417,921 142,635 shares@ $2.94 avg price | Exited |
KYTXKyverna Therapeutics Inc
| 0% | $358,875 47,850 shares@ $7.5 avg price | Exited |